Now playing Next Health news Girls are experiencing earlier and more irregular periods, study says A recent study found that girls are starting menstruation earlier and experiencing more irregular cycles, which could be influenced by factors like obesity and environmental chemicals. 30/05/2024
Now playing Next Health news Prenatal exposure to chemicals may increase risk of childhood obesity Exposure to endocrine-disrupting chemicals during pregnancy may increase the risk of obesity and hypertension in children, new research suggests. 28/05/2024
Now playing Next Health news 'Ozempic breasts': What are the side effects of weight loss drugs? While many people suffering from obesity have been using Ozempic to help with weight loss, health professionals are warning of potential side effects. 19/05/2024
Now playing Next wellbeing COVID linked to less activity, more screen time among children A new report from WHO said that the COVID-19 pandemic led to more screen time and less physical activity among European children. 15/05/2024
Now playing Next Health news Ozempic found to cut heart disease and keep weight off for four years New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular weight-loss drug. 14/05/2024
Now playing Next Health news What is the sugar scandal hitting Nestlé and what happens now? A new investigation found that one portion of Nestlé cereal for six-months-old babies contained around a cube and a half of sugar per serving. 19/04/2024
Now playing Next Health news More people worldwide are suffering from neurological issues than ever Researchers warn the cost to health systems around the world will be severe if more is not done to prevent and treat these diseases. 27/03/2024
Now playing Next Business How much higher can Novo Nordisk shares go? Novo Nordisk's remarkable ascent, driven by its revolutionary weight-loss drug Wegovy, has led to a surge in market value and positive analyst outlook. 14/03/2024
Now playing Next Business Novo Nordisk expands lead on Tesla on upbeat obesity drug trial Novo Nordisk, of anti-obesity drug Wegovy fame, reveals encouraging initial trial data for new weight loss drug that could potentially overtake Wegovy. 08/03/2024
Now playing Next Health news More than one billion people globally are obese, study finds Obesity rates have increased dramatically among children, teenagers, and adults, with more than one billion people in the world now affected. 01/03/2024
Now playing Next Health news Ozempic, Wegovy not linked to increased risk of suicidal thoughts The researchers called for closer evaluation of reports of suicidal thoughts linked to the diabetes and obesity drugs and for patients to be followed for a longer period of time. 08/01/2024
Now playing Next Nutrition Europe's obesity crisis: Which countries are the most impacted? The data shows one in six Europeans with obese and over 50% of adults overweight. The rates vary from country to country but where is the problem the worst? 20/12/2023
Now playing Next Health news Americans turn to alternatives amid Ozempic shortage Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug. 04/12/2023
Now playing Next Business AstraZeneca announces new anti-obesity drug deal and positive profit AstraZeneca's share price climbed on Thursday after it announced a multi-billion dollar deal with Chinese biopharmaceutical company Eccogene to produce a new anti-diabetes and obesity drug. 10/11/2023
Now playing Next Health news Patients hospitalised after using counterfeit weight-loss drugs Austria’s health authorities said they had reports that Ozempic counterfeit medicine had reached patients. UK regulators also said a small number of patients were hospitalised. 30/10/2023
Now playing Next Health news UK's NHS gets limited supply of new Wegovy weight loss drug Wegovy, manufactured by Danish pharmaceutical company Novo Nordisk, is a popular new weight loss drug. 04/09/2023
Now playing Next Health news Anti-obesity drug market booming with new class of popular drugs Designed to treat obesity, a new class of drugs is also an opportunity for investors. 24/08/2023
Now playing Next Health news Weight-loss drug Wegovy could reduce risk of heart attack or stroke Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient. 09/08/2023
Now playing Next Health news UK launches €46.5m project to tackle obesity with weight loss drugs The UK is pouring millions into a programme to tackle obesity with weight loss drugs such as Wegovy. 07/06/2023
Now playing Next New Zealand Air New Zealand weighing passengers before boarding flights New Zealand's national airline is asking passengers to step on the scales before they board international flights as part of a month-long survey of the weight and balance of its planes before takeoff. 31/05/2023